Critical Therapeutics to Webcast New York Meeting with Institutional Investors and Analysts
LEXINGTON, Mass.--(BUSINESS WIRE)--Sept. 14, 2005--Critical Therapeutics, Inc. (Nasdaq:CRTX - News) will host a meeting in New York City with members of the financial community on Tuesday, September 20, 2005. A live webcast of the meeting will begin at 12:30 p.m. ET.
Members of Critical Therapeutics' senior management team will discuss the Company's strategy and operations, including the planned launch - pending regulatory approval - of ZYFLO® Filmtab® (zileuton tablets) for asthma. Management also will review the status of the Company's drug discovery and development pipeline.
Presenters include:
Paul Rubin, M.D., President and Chief Executive Officer
Frank Thomas, Senior Vice President and Chief Financial Officer
Rick Finnegan, Senior Vice President of Sales and Marketing
Who: Critical Therapeutics, Inc.
What: New York Analyst Meeting
When: 12:30 p.m. ET Tuesday, September 20, 2005 - live webcast
begins
How: A live audio webcast of the meeting will be available by logging on to the "Investors" section of the Company's website, www.crtx.com, and clicking on the "Live Webcast" icon on the Investors Overview page. A replay of the webcast will be available for 60 days following the live presentation. |
